PMZ-1620 (Sovateltide) in Mild to Moderate Alzheimer's Disease

NCT04052737 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Dementia

Interventions

DRUG: Normal Saline along with standard treatment
DRUG: PMZ-1620 (sovateltide) along with standard treatment

Sponsor

Pharmazz, Inc.